ASBMB Annual Meeting to feature talks on the biochemistry of aging

April 18, 2009

Five-hundred years ago, Ponce de Leon combed the swamps of Florida seeking the legendary "fountain of youth." This week, at the 2009 ASBMB Annual Meeting in New Orleans (held in conjunction with Experimental Biology 2009) will feature a range of exciting talks centering on the new molecular "fountain of youth," the genes and pathways that influence lifespan. While the secrets of longevity may still be a long time away, the presentations at ASBMB illustrate that we are at least beginning to understand the intricate connections between diet, metabolism, aging, and disease.

Some of these aging-related presentations include:

Regulation of Obesity, Heart Function, and Lifespan by the Nutrient Sensing TOR Pathway
Sean Michael Oldham, Burnham Institute for Medical Research, La Jolla, CA
(Sun, April 19 3:30 PM - 5:50 PM, Room: 356)

Metabolic balance is a highly regulated process, and genetic and/or diet-induced imbalances (like a high fat diet, HFD) bring about increased susceptibility to obesity, diabetes, cardiovascular disease, and cancer. Oldham's group has established a fruit fly model to study the genes and environmental factors responsible for mediating HFD induced obesity. They found that inhibiting the Target of Rapamycin (TOR) pathway, involved in nutrient sensing, can block the detrimental effects of a HFD. They also found that reducing the levels of TOR can mimic a calorie-restricted diet and improve metabolism, heart function and longevity. Thus, in addition to potentially linking HFD-obesity to diabetes and heart disease, TOR might be a central mediator of lifespan.

Conserved Links Between Nutrient Signaling, Translation and Aging
Brian Kennedy, University of Washington, Seattle
(Wed, April 22 8:30 AM - 10:50 AM, Room: 356)

While model organisms like fruit flies have been invaluable in identifying hundreds of genes associated with aging, there is still concern that any increases in fly lifespan simply cannot be expected to work in mammals. Kennedy and his group examined this issue by carefully analyzing age-related genes in yeast and the C. elegans worm, two organisms that diverged over a billion years ago. They found a statistically significant connection in the genes and pathways that affect aging in both organisms, including reduced mTOR signaling. They suggest that the conservation of aging genes across animals exists not because specific genes have evolved to regulate aging, but rather because animals have evolved a similar response to nutrient restriction, and lifespan is tightly linked to this response, providing evidence that efforts in humans just might work.

The Role of Insulin-like Signaling for the Central and Peripheral Regulation of Nutrient Homeostasis and Life Span
Morris White, Children's Hospital Boston, MA
(Tue, April 21 3:30 PM - 5:50 PM, Room: 356)

White will discuss some of his group's work in manipulating the levels of various insulin receptor substrates in mice. Insulin-like signaling regulates the storage and usage of nutrients, a process best exemplified by insulin's role in keeping blood glucose levels from getting too low or high; therefore proper insulin-like signaling is absolutely critical for growth and development. Interestingly, though, in lower animals like fruit flies and nematodes, reduced insulin secretion can extend lifespan. White will show some interesting studies suggesting that reduced insulin-like signaling in the brain can have a consistent effect in extending mammalian lifespan --just as seen in worms and flies.

Cancer and Aging in DNA Repair Deficiency: Cause and Treatment
Laura J. Niedernhofer, University of Pittsburgh, PA
(Wed, April 22 12:50 PM - 3:10 PM, Room: 355)

Finding the keys to slow down aging requires a better understanding of the natural aging process. In that regard, progeroid syndromes, characterized by accelerated aging and increased risks of cancer, have been valuable models. Niedernhofer and her lab have developed a mouse model that expresses sub-normal levels of ERCC1-XPF endonuclease, an enzyme that is important in DNA repair. Starting at 8 weeks of life, the mice display progressive symptoms associated with aging including muscle wasting, loss of vision and hearing, urinary incontinence, decreased liver and kidney function, and osteoporosis. These mice offer a great system to identify the mechanisms by which DNA damage can drive the tissue degeneration associated with aging as well as a platform to test anti-aging therapies like stem cells and free radical scavengers.
-end-
For more information prior to the meeting, and for any interested parties who cannot attend, please contact Nick Zagorski (301-634-7366, nzagorski@asbmb.org)

For more on-site information or to arrange any meetings, please contact Sarah Goodwin, 770-722-0155 before April 18, 504-670-4513 April 18-April 22

The American Society for Biochemistry and Molecular Biology is a nonprofit scientific and educational organization with over 11,900 members in the United States and internationally. Most members teach and conduct research at colleges and universities. Others conduct research in various government laboratories, nonprofit research institutions and industry. The Society's student members attend undergraduate or graduate institutions. Founded in 1906, the Society is based in Bethesda, Maryland, on the campus of the Federation of American Societies for Experimental Biology. The Society's purpose is to advance the science of biochemistry and molecular biology through publication of the Journal of Biological Chemistry, the Journal of Lipid Research, and Molecular and Cellular Proteomics, organization of scientific meetings, advocacy for funding of basic research and education, support of science education at all levels, and promoting the diversity of individuals entering the scientific work force. For more information about ASBMB, see the Society's Web site at www.asbmb.org.

American Society for Biochemistry and Molecular Biology

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.